BUY MBP CLADRIBINE CLADRIM VIAL BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Cladribine is a medicine used to treat certain types of cancer and autoimmune diseases, most commonly hairy cell leukemia and multiple sclerosis (MS) in specific formulations. It belongs to a group of medicines called purine analogues, which interfere with the DNA of abnormal cells, preventing them from multiplying and causing them to die.

Cladribine works by entering cells and disrupting DNA synthesis and repair. It mainly affects rapidly dividing cells such as cancer cells and certain immune cells. In multiple sclerosis, cladribine selectively reduces specific immune cells that are responsible for inflammation and nerve damage, helping to reduce disease activity while allowing the immune system to rebuild in a more controlled way.

Cladribine may be given by injection or by mouth, depending on the condition being treated. For cancer treatment, it is usually given by intravenous infusion over several days as part of a treatment cycle. For multiple sclerosis, cladribine is given orally in short treatment courses spread over two years, rather than continuous daily treatment. The exact dose and schedule depend on the medical condition, body weight, and overall health.

One of the most important effects of cladribine is suppression of the immune system. It lowers white blood cell counts, particularly lymphocytes, which can increase the risk of infections. Because of this, blood tests are done regularly before, during, and after treatment to monitor immune cell levels. Patients are advised to report any signs of infection such as fever, sore throat, cough, or unusual tiredness immediately.

Common side effects of cladribine include fatigue, headache, nausea, fever, and mild infections. Some people may experience hair thinning, skin rashes, or injection site reactions. These effects are usually temporary and improve with time.

More serious side effects can occur, including severe infections such as shingles or pneumonia, especially when immune cell counts are very low. Reactivation of latent infections such as tuberculosis or hepatitis may also occur, so screening is often done before starting treatment. Because cladribine suppresses the immune system, live vaccines should not be given during or shortly after treatment.

Cladribine may increase the risk of developing certain cancers over time, so it is used only when the benefits clearly outweigh the risks. Long-term follow-up and regular health monitoring are essential after treatment.

Cladribine can cause harm to an unborn baby and must not be used during pregnancy or breastfeeding. Effective contraception is required during treatment and for several months after the last dose for both men and women. Pregnancy testing is usually done before starting treatment.

Patients receiving cladribine should avoid close contact with people who have infections and should practice good hygiene to reduce infection risk. Any unusual symptoms such as persistent fever, unexplained bruising, bleeding, or extreme fatigue should be reported immediately.

When used appropriately under specialist supervision, cladribine can be a highly effective treatment that helps control disease activity, reduce relapses, and improve quality of life. Regular follow-up, blood monitoring, and strict adherence to medical advice are essential for safe and effective treatment.